Minor pharmas could become next prey
The $2.7 billion bid for hospital operator Healthscope has turned the corporate action spotlight on the health care sector, particularly the smaller end of the market.
The $2.7 billion bid for hospital operator Healthscope has turned the corporate action spotlight on the health care sector with activity potentially concentrated at the smaller end of the market.
Predators could be spoilt for choice when it comes to hunting for depressed assets. Given the fragile appetite for risk and tight credit conditions, some experts believe bidders would generally be keener on making smaller bolt-on acquisitions that are easier to pull off and integrate.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Companies
Fetching latest articles